940 related articles for article (PubMed ID: 29692177)
1. Constructing Redox-Responsive Metal-Organic Framework Nanocarriers for Anticancer Drug Delivery.
Lei B; Wang M; Jiang Z; Qi W; Su R; He Z
ACS Appl Mater Interfaces; 2018 May; 10(19):16698-16706. PubMed ID: 29692177
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
[TBL] [Abstract][Full Text] [Related]
3. A tumor-sensitive biological metal-organic complex for drug delivery and cancer therapy.
Jiang Z; Wang T; Yuan S; Wang M; Qi W; Su R; He Z
J Mater Chem B; 2020 Aug; 8(32):7189-7196. PubMed ID: 32618980
[TBL] [Abstract][Full Text] [Related]
4. Advances in antitumor nanomedicine based on functional metal-organic frameworks beyond drug carriers.
Wei Q; Wu Y; Liu F; Cao J; Liu J
J Mater Chem B; 2022 Feb; 10(5):676-699. PubMed ID: 35043825
[TBL] [Abstract][Full Text] [Related]
5. Stimuli-Responsive Design of Metal-Organic Frameworks for Cancer Theranostics: Current Challenges and Future Perspective.
Pantwalawalkar J; Mhettar P; Nangare S; Mali R; Ghule A; Patil P; Mohite S; More H; Jadhav N
ACS Biomater Sci Eng; 2023 Aug; 9(8):4497-4526. PubMed ID: 37526605
[TBL] [Abstract][Full Text] [Related]
6. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer Targeting of a Drug Delivery System through Postsynthetic Modification of Curcumin@N
Alves RC; Schulte ZM; Luiz MT; Bento da Silva P; Frem RCG; Rosi NL; Chorilli M
Inorg Chem; 2021 Aug; 60(16):11739-11744. PubMed ID: 34101467
[TBL] [Abstract][Full Text] [Related]
8. Metal-Organic Framework (MOF)-Based Drug/Cargo Delivery and Cancer Therapy.
Wu MX; Yang YW
Adv Mater; 2017 Jun; 29(23):. PubMed ID: 28370555
[TBL] [Abstract][Full Text] [Related]
9. Charge Transport in Zirconium-Based Metal-Organic Frameworks.
Kung CW; Goswami S; Hod I; Wang TC; Duan J; Farha OK; Hupp JT
Acc Chem Res; 2020 Jun; 53(6):1187-1195. PubMed ID: 32401008
[TBL] [Abstract][Full Text] [Related]
10. Metal-Organic Framework (MOF)-based Nanomaterials for Biomedical Applications.
Luo Z; Fan S; Gu C; Liu W; Chen J; Li B; Liu J
Curr Med Chem; 2019; 26(18):3341-3369. PubMed ID: 29446726
[TBL] [Abstract][Full Text] [Related]
11. Metal-Organic Framework Derived Nanozymes in Biomedicine.
Wang D; Jana D; Zhao Y
Acc Chem Res; 2020 Jul; 53(7):1389-1400. PubMed ID: 32597637
[TBL] [Abstract][Full Text] [Related]
12. Folic Acid Functionalized Zirconium-Based Metal-Organic Frameworks as Drug Carriers for Active Tumor-Targeted Drug Delivery.
Dong H; Yang GX; Zhang X; Meng XB; Sheng JL; Sun XJ; Feng YJ; Zhang FM
Chemistry; 2018 Nov; 24(64):17148-17154. PubMed ID: 30125400
[TBL] [Abstract][Full Text] [Related]
13. Advances in the use of MOFs for Cancer Diagnosis and Treatment: An Overview.
Abuçafy MP; da Silva BL; Oshiro-Junior JA; Manaia EB; Chiari-Andréo BG; Armando RAM; Frem RCG; Chiavacci LA
Curr Pharm Des; 2020; 26(33):4174-4184. PubMed ID: 32250216
[TBL] [Abstract][Full Text] [Related]
14. Nanoscale metal-organic frameworks as key players in the context of drug delivery: evolution toward theranostic platforms.
Carrillo-Carrión C
Anal Bioanal Chem; 2020 Jan; 412(1):37-54. PubMed ID: 31734711
[TBL] [Abstract][Full Text] [Related]
15. Metal-Organic Framework (MOF)-Based Drug Delivery.
Cao J; Li X; Tian H
Curr Med Chem; 2020; 27(35):5949-5969. PubMed ID: 31215374
[TBL] [Abstract][Full Text] [Related]
16. Stepwise Synthesis of Metal-Organic Frameworks.
Bosch M; Yuan S; Rutledge W; Zhou HC
Acc Chem Res; 2017 Apr; 50(4):857-865. PubMed ID: 28350434
[TBL] [Abstract][Full Text] [Related]
17. Biomedical application of metal-organic frameworks (MOFs) in cancer therapy: Stimuli-responsive and biomimetic nanocomposites in targeted delivery, phototherapy and diagnosis.
Li B; Ashrafizadeh M; Jiao T
Int J Biol Macromol; 2024 Mar; 260(Pt 2):129391. PubMed ID: 38242413
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in Metal-Organic Frameworks as nanocarriers for triggered release of anticancer drugs: Brief history, biomedical applications, challenges and future perspective.
Fatima SF; Sabouni R; Garg R; Gomaa H
Colloids Surf B Biointerfaces; 2023 May; 225():113266. PubMed ID: 36947901
[TBL] [Abstract][Full Text] [Related]
19. Surface-Functionalization of Zr-Fumarate MOF for Selective Cytotoxicity and Immune System Compatibility in Nanoscale Drug Delivery.
Abánades Lázaro I; Haddad S; Rodrigo-Muñoz JM; Marshall RJ; Sastre B; Del Pozo V; Fairen-Jimenez D; Forgan RS
ACS Appl Mater Interfaces; 2018 Sep; 10(37):31146-31157. PubMed ID: 30136840
[TBL] [Abstract][Full Text] [Related]
20. Metal-Organic Framework-Templated Biomaterials: Recent Progress in Synthesis, Functionalization, and Applications.
Begum S; Hassan Z; Bräse S; Wöll C; Tsotsalas M
Acc Chem Res; 2019 Jun; 52(6):1598-1610. PubMed ID: 30977634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
